Carolyn Taylor Acquires 1,415 Shares of TNXP
Carolyn Taylor bought 1,415 shares of TNXP at $10.55 per share on June 12, 2026.
Key Points
- Carolyn Taylor purchased 1,415 shares of TNXP at $10.55 each on June 12, 2026, for a total of $14,928.25.
- Shares of TNXP traded at $11.35, with a recent insider buying spree by several executives.
- Analysts at TD Cowen initiated coverage on TNXP with a 'buy' rating and a $22 price target on May 4, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Carolyn Taylor made a significant move by purchasing 1,415 shares of TNXP on June 12, 2026. She paid $10.55 per share, bringing her total investment to $14,928.25. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at Tonix Pharmaceuticals Holding Corp.
Several insiders have been active in buying TNXP shares recently. On June 9, 2026, CEO Seth Lederman acquired 5,000 shares at $11.79 each. Just a day before, on June 8, Richard Newcomb Stillwell bought 5,000 shares at $11.65 per share. Additionally, in May, Richard Bagger, Richard Newcomb Stillwell, and David Grange each bought 22,700 shares, although the price for these transactions was not disclosed.
Other Institutional Activity in TNXP
Institutional investors have shown interest in TNXP as well. BlackRock, Inc. increased its holdings by 83,296 shares, ending with 968,177 shares valued at about $13.31 million. Vanguard Capital Management LLC added 518,650 shares, now holding the same amount worth approximately $7.13 million. Citadel Advisors LLC also picked up 468,712 shares, valued at around $6.44 million. Jones Hill Capital LP matched this move with 452,116 shares, valued at $6.22 million. Geode Capital Management, LLC upped its stake by 41,387 shares, totaling 313,291 shares valued at $4.31 million. Balyasny Asset Management L.P. made a substantial increase of 127,730 shares, bringing its total to 313,082 shares worth $4.30 million.
Analysts Set New Price Targets
On May 4, 2026, TD Cowen initiated coverage on TNXP with a 'buy' rating and set a price target of $22. Noble Capital Markets reiterated its 'buy' rating with a target price of $70 back in March 2025. Alliance Global Partners maintained its 'buy' rating with an $11 target as of July 2024.
Bottom Line
Carolyn Taylor's purchase of TNXP shares is part of a broader trend of insider buying, which may suggest confidence in the company's future. The stock, trading at $11.35, has seen increased interest from both insiders and institutions. Analysts have also shown optimism, with several firms maintaining 'buy' ratings and setting ambitious price targets. As always, while these insights provide a snapshot of recent activity, they reflect past decisions and may not indicate future performance.
Get Tonix Pharmaceuticals Holding Corp. alerts
New 13F filings, insider trades, and analyst moves on $TNXP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.